ERG expression in BPH vs prostatic adenocarcinoma and its correlation with Gleason grade group

Area of Science:

• Oncology
• Pathology
• Molecular Biology

Background:

• Prostate carcinoma and benign prostate hyperplasia (BPH) are common prostate conditions.
• Distinguishing between prostate carcinoma and BPH is crucial for appropriate patient management.
• Immunohistochemical markers can aid in differential diagnosis.

Purpose of the Study:

• To evaluate the immunohistochemical expression of erythroblast transformation-specific-related gene (ERG) in prostate carcinoma and BPH.
• To determine the association of ERG expression with Gleason grade groups in prostate carcinoma.
• To assess ERG's potential as a diagnostic marker differentiating prostate carcinoma from BPH.

Main Methods:

• A retrospective study analyzed 60 prostate tissue samples (33 prostate carcinoma, 27 BPH).
• Immunohistochemical staining was performed to detect ERG expression.
• Data analysis compared ERG expression in prostate carcinoma versus BPH and correlated it with Gleason grades.

Main Results:

• ERG showed positive nuclear staining in 60.6% of prostate carcinoma cases.
• All BPH cases (100%) exhibited negative ERG immunohistochemical expression.
• ERG expression was not significantly associated with Gleason grade groups in prostate carcinoma (p>0.05).

Conclusions:

• ERG expression is significantly associated with prostate carcinoma compared to BPH.
• ERG can serve as a valuable diagnostic tool to differentiate prostate carcinoma from benign prostate hyperplasia.
• Further research may explore ERG's role in prostate cancer prognostication.